Vimta Labs informs about unaudited financial results

27 Jan 2023 Evaluate

Pursuant to Regulation 30 and 33 of SEBI (Listing obligations and disclosure requirements) 2015, Vimta Labs has informed that it enclosed Standalone and Consolidated Unaudited Financial Results for the third quarter ended 31st December 2022, along with Limited Review Report. Copy of the Unaudited Financial results are also posted on the company’s website: https://vimta.comlinvestors/financial-statements/. Abridged financials are being published in the newspapers (copy enclosed). The meeting commenced at 11:30 am and ended at 03:00 pm.

The above information is a part of company’s filings submitted to BSE.

Vimta Labs Share Price

450.00 -5.65 (-1.24%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.